Completed PHASE4 INTERVENTIONAL 2-arm NCT01935115

Comparing Ketamine and Propofol Anesthesia for Electroconvulsive Therapy

A Prospective Randomized Double Blinded Control Trial Using Ketamine or Propofol Anesthesia for Electroconvulsive Therapy: Improving Treatment-Resistant Depression

Sponsor: Royal University Hospital Foundation

Conditions Treatment Resistant Depression

Interventions Ketamine Propofol

Updated 5 times since 2017 Last updated: Sep 12, 2017 Started: Sep 30, 2013 Primary completion: Mar 31, 2016 Completion: Mar 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Treatment Resistant Depression, this trial is completed. The trial is conducted by Royal University Hospital Foundation and has accumulated 5 data snapshots since 2013. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Royal University Hospital Foundation
Saskatoon Health Region
Schulman Research Award
University of Saskatchewan

Data source: University of Saskatchewan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Saskatoon, Canada